Cameco and other uranium/reactor stocks jump on investor focus on new U.S. reactor framework and AI-driven nuclear demand tailwinds.

Cameco (CCJ) shares rose 7.2% on October 6, driven primarily by renewed investor interest following the announcement of a new U.S.-South Korea framework for nuclear reactor deployment. The move was supported by strength in the broader nuclear fuel outlook, as Cameco has recently pointed to improving uranium pricing and long-term demand fundamentals.

On September 30, the U.S. and South Korea announced a framework contemplating up to US$120 billion to help finance the buildout of Westinghouse reactor technology in the United States. The framework outlines potential construction of up to eight large reactors domestically, including six AP1000 units and up to two APR1400 units, all built on Westinghouse technology in which Cameco holds an economic interest.

Cameco has stated that Westinghouse is seeing a large pipeline of reactor opportunities, which could create follow-on value for both Westinghouse and Cameco's uranium and fuel services businesses. In its latest quarterly update, Cameco also raised parts of its uranium-segment outlook to reflect a higher UxC spot price, reinforcing the view that improving fuel market conditions are providing support to sentiment.

In recent institutional activity, 472 investors added shares of CCJ in their most recent quarter, while 431 decreased positions. Notable additions included JPMorgan Chase & Co., which added 4.2 million shares for an estimated $427.7 million in Q2 2026, and D.E. Shaw & Co., which added 1.8 million shares valued at approximately $183.5 million. The Canada Pension Plan Investment Board added 1.66 million shares worth $169.2 million, representing a 67.3% increase to their position.

Wall Street analyst sentiment remains constructive, with William Blair maintaining an "Outperform" rating as of April 2026. Analyst price targets over the past six months range from $108 to $175, with a median target of $140.